Multimodal MRI-based study in patients with SPG4 mutations
- PMID: 25658484
- PMCID: PMC4320056
- DOI: 10.1371/journal.pone.0117666
Multimodal MRI-based study in patients with SPG4 mutations
Abstract
Mutations in the SPG4 gene (SPG4-HSP) are the most frequent cause of hereditary spastic paraplegia, but the extent of the neurodegeneration related to the disease is not yet known. Therefore, our objective is to identify regions of the central nervous system damaged in patients with SPG4-HSP using a multi-modal neuroimaging approach. In addition, we aimed to identify possible clinical correlates of such damage. Eleven patients (mean age 46.0 ± 15.0 years, 8 men) with molecular confirmation of hereditary spastic paraplegia, and 23 matched healthy controls (mean age 51.4 ± 14.1years, 17 men) underwent MRI scans in a 3T scanner. We used 3D T1 images to perform volumetric measurements of the brain and spinal cord. We then performed tract-based spatial statistics and tractography analyses of diffusion tensor images to assess microstructural integrity of white matter tracts. Disease severity was quantified with the Spastic Paraplegia Rating Scale. Correlations were then carried out between MRI metrics and clinical data. Volumetric analyses did not identify macroscopic abnormalities in the brain of hereditary spastic paraplegia patients. In contrast, we found extensive fractional anisotropy reduction in the corticospinal tracts, cingulate gyri and splenium of the corpus callosum. Spinal cord morphometry identified atrophy without flattening in the group of patients with hereditary spastic paraplegia. Fractional anisotropy of the corpus callosum and pyramidal tracts did correlate with disease severity. Hereditary spastic paraplegia is characterized by relative sparing of the cortical mantle and remarkable damage to the distal portions of the corticospinal tracts, extending into the spinal cord.
Conflict of interest statement
Figures
Similar articles
-
Diffusion tensor imaging in SPG11- and SPG4-linked hereditary spastic paraplegia.Int J Neurosci. 2014 Apr;124(4):261-70. doi: 10.3109/00207454.2013.836705. Epub 2013 Sep 27. Int J Neurosci. 2014. PMID: 23968121
-
Gray and white matter alterations in hereditary spastic paraplegia type SPG4 and clinical correlations.J Neurol. 2015 Aug;262(8):1961-71. doi: 10.1007/s00415-015-7791-7. Epub 2015 Jun 9. J Neurol. 2015. PMID: 26050637
-
SPG11 mutations cause widespread white matter and basal ganglia abnormalities, but restricted cortical damage.Neuroimage Clin. 2018 Jun 9;19:848-857. doi: 10.1016/j.nicl.2018.05.031. eCollection 2018. Neuroimage Clin. 2018. PMID: 29946510 Free PMC article.
-
Autosomal dominant spastic paraplegias: a review of 89 families resulting from a portuguese survey.JAMA Neurol. 2013 Apr;70(4):481-7. doi: 10.1001/jamaneurol.2013.1956. JAMA Neurol. 2013. PMID: 23400676 Review.
-
Hereditary spastic paraplegia SPG4: what is known and not known about the disease.Brain. 2015 Sep;138(Pt 9):2471-84. doi: 10.1093/brain/awv178. Epub 2015 Jun 20. Brain. 2015. PMID: 26094131 Free PMC article. Review.
Cited by
-
Outcome Measures and Biomarkers for Clinical Trials in Hereditary Spastic Paraplegia: A Scoping Review.Genes (Basel). 2023 Sep 3;14(9):1756. doi: 10.3390/genes14091756. Genes (Basel). 2023. PMID: 37761896 Free PMC article. Review.
-
Dysfunctional neuro-muscular mechanisms explain gradual gait changes in prodromal spastic paraplegia.J Neuroeng Rehabil. 2023 Jul 15;20(1):90. doi: 10.1186/s12984-023-01206-8. J Neuroeng Rehabil. 2023. PMID: 37454121 Free PMC article.
-
Proof of principle for the clinical use of a CE-certified automatic imaging analysis tool in rare diseases studying hereditary spastic paraplegia type 4 (SPG4).Sci Rep. 2022 Dec 21;12(1):22075. doi: 10.1038/s41598-022-25545-z. Sci Rep. 2022. PMID: 36543827 Free PMC article.
-
Progressive Spinal Cord Degeneration in Friedreich's Ataxia: Results from ENIGMA-Ataxia.Mov Disord. 2023 Jan;38(1):45-56. doi: 10.1002/mds.29261. Epub 2022 Oct 29. Mov Disord. 2023. PMID: 36308733 Free PMC article.
-
Characteristics of serum neurofilament light chain as a biomarker in hereditary spastic paraplegia type 4.Ann Clin Transl Neurol. 2022 Mar;9(3):326-338. doi: 10.1002/acn3.51518. Epub 2022 Feb 16. Ann Clin Transl Neurol. 2022. PMID: 35171517 Free PMC article.
References
-
- Charvin D, Cifuentes-Diaz C, Fonknechten N, Joshi V, Hazan J, et al. (2003) Mutations of SPG4 are responsible for a loss of function of spastin, an abundant neuronal protein localized in the nucleus. Hum Mol Genet 12:71–8. - PubMed
-
- Duning T, Warnecke T, Schirmacher A, Schiffbauer H, Lohmann H, et al. (2010) Specific pattern of early white-matter changes in pure hereditary spastic paraplegia. MovDisord 25:1986–92. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
